Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BIIB

Biogen

$317.93

-0.25 (-0.08%)

, CBAY

CymaBay

10:29
09/20/17
09/20
10:29
09/20/17
10:29
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

BIIB

Biogen

$317.93

-0.25 (-0.08%)

CBAY

CymaBay

EVH

Evolent Health

$16.18

0.5299 (3.39%)

EPZM

Epizyme

$19.25

1.4 (7.84%)

INTU

Intuit

$145.34

1.54 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 03

    Oct

  • 22

    Oct

  • 25

    Oct

Tuesday
CBAY

CymaBay

17:49
09/19/17
09/19
17:49
09/19/17
17:49
Initiation
CymaBay initiated at Cantor »

CymaBay initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

Over a week ago
CBAY

CymaBay

$6.86

0.13 (1.93%)

, ICPT

Intercept

$90.75

-7.37 (-7.51%)

07:14
09/14/17
09/14
07:14
09/14/17
07:14
Recommendations
CymaBay, Intercept analyst commentary at Oppenheimer »

Intercept Ocaliva…

CBAY

CymaBay

$6.86

0.13 (1.93%)

ICPT

Intercept

$90.75

-7.37 (-7.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CBAY

CymaBay

$5.95

-0.15 (-2.46%)

08:20
09/11/17
09/11
08:20
09/11/17
08:20
Hot Stocks
CymaBay granted EMA Orphan Drug Designation for seladelpar »

CymaBay Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

$6.33

-0.12 (-1.86%)

07:20
08/23/17
08/23
07:20
08/23/17
07:20
Initiation
CymaBay initiated at Leerink »

CymaBay initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
CBAY

CymaBay

$6.24

-0.01 (-0.16%)

07:33
08/18/17
08/18
07:33
08/18/17
07:33
Initiation
CymaBay initiated at SunTrust »

CymaBay initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

$6.66

-0.29 (-4.17%)

11:49
08/11/17
08/11
11:49
08/11/17
11:49
Downgrade
CymaBay rating change at IFS Securities »

CymaBay downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

$6.66

-0.29 (-4.17%)

16:05
08/10/17
08/10
16:05
08/10/17
16:05
Earnings
CymaBay reports Q2 EPS (31c), consensus (26c) »

The increase in net loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

CBAY

CymaBay

$7.93

0.18 (2.32%)

06:04
07/25/17
07/25
06:04
07/25/17
06:04
Recommendations
CymaBay analyst commentary at Piper Jaffray »

CymaBay price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

$7.37

0.43 (6.20%)

07:25
07/20/17
07/20
07:25
07/20/17
07:25
Recommendations
CymaBay analyst commentary at Oppenheimer »

CymaBay price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.